Picture of Ethernity Networks logo

ENET Ethernity Networks News Story

0.000.00%
gb flag iconLast trade - 00:00
TechnologyHighly SpeculativeMicro CapNeutral

REG - Ethernity Networks - Interim Results

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230920:nRST9804Ma&default-theme=true

RNS Number : 9804M  Ethernity Networks Ltd  20 September 2023

 

20 September 2023

 

 

ETHERNITY NETWORKS LTD

("Ethernity" or the "Company" or the "Group")

 

Interim results for the six months ended 30 June 2023

 

Ethernity Networks Ltd (AIM: ENET.L; OTCMKTS: ENETF), a leading supplier of
networking processing semiconductor technology ported on field programmable
gate arrays ("FPGAs") for virtualised networking appliances, announces its
interim results for the six months ended 30 June 2023.

 

Financial summary

·   Revenues increased by 98% to $1,398,871 (H1 2022: $704,853).

·  Gross profit increased by 87% to $802,494 over the comparable period (H1
2022: $428,761), and an underlying gross profit of $996,031 without the
non-recurring IFRS impairment which reflects an increase of 132% vs H1 2022.

·  Gross margin of 57.37% (H1 2022 60.83%) and an underlying gross margin
of 71.2% without the non-recurring IFRS impairment.

·   Net comprehensive loss for the period increased by $111,716 to
$3,614,449 (H1 2022: $3,502,733). This is due to IFRS finance income
recognized in H1 2022 in respect of the fundraising undertaken in that period.

·   Research and Development, General and Administrative, and Marketing
expenses (before amortisation, depreciation and IFRS adjustments) decreased
overall by 3%.

·    Adjusted EBITDA loss decreased by 19% to $3,045,037 (H1 2022:
$3,782,342).

 

Current trading

 

The Company is targeting the achievement of positive cash flow generation from
operations during the second half of 2023 by continuing to fulfill customers'
orders and from anticipated revenue from new contracts, in combination with a
reduction in expenses. The Company anticipates that revenue growth will be
achieved as a result of the modified business model which focuses on the
licensing of data processing, passive optical network ("PON") and software
technology.

 

As of today, 950,000 platforms have been deployed with the ENET data
processing technology, in various types of platforms including Carrier
Ethernet Demarcation devices, wireless backhaul, cellular base stations,
Broadband fiber and DSL platform, Broadband fix wireless platforms and
aerospace aviation platforms. The Company continues to generate steady revenue
from existing customers in all the above fields.

 

Recently, after immense efforts and logistics, the Company's U.S. based Tier 1
Aerospace client received U.S. Government approval to work with the Company on
a military project that is based on the ENET Data processor adapted for the
aviation market.

 

Additionally, the Company has expanded the offering of its standard ENET data
processing solution with a network operating system that delivers a complete
software stack for system operation. This expansion provides an opportunity
for revenue growth and an increase in gross margin for each delivery of an
ENET Flow processor. It also allows the Company to expand its customer base
among those that do not obtain the complete software capabilities for
networking functions to deliver customized FPGAs, customized FPGA based
systems, or customized eASIC for medium volume platforms.

 

Company Strategy

 

Ethernity's data processing and PON firmware and software can be ported into
AMD's low-cost FPGA, Microchip's FPGAs, Intel's FPGAs or Intel's eASIC,
dependent on the application, the platform and the volume of the business, for
use in mass production with customized features. The ASIC process requires
large investment, however the same Firmware that runs on a FPGA can be
repurposed for a reduced cost through an eASIC, which requires c. 20% of the
investment needed for fabricating a pure ASIC and has a significantly shorter
time to market. Therefore, the eASIC can be used for medium volume markets,
such as telecom equipment, and provides a considerably lower cost and lower
power option than an FPGA. Furthermore, for large volume markets such as
Residential Gateways Customer Premises Equipment ("CPE") devices that
represents a market of tens of millions of units a year, the ENET Data
processing and PON firmware can be utilized on pure ASIC to capture the right
price for customer located devices.

 

The Company's PON technology spans into different market segments including
Fiber-To-The-Room, PON Optical Line Terminal ("OLT") Sticks that utilize PON
OLT MAC within optical transceiver, remote OLTs with main requirements to
support Combo PON, that essentially runs 10G PON and legacy Giga Bit PON
("GPON") over single fibre, and traditional OLTs with multiple PON ports that
will be severed by an eASIC process. Furthermore, the Company plans further
PON business expansion with 25Gbps PON and 50Gbps PON.

 

The business model for both the PON and the ENET Flow processor is based on
licensing the technology to be implemented on FPGA or eASIC, along with an
associated software package, which lowers the time to market for the customers
and reduces the time it takes for Ethernity to earn revenue.

 

The combination of this model of delivering our solution on FPGA for unique
and customized platform or an eASIC offering for larger volume markets, should
allow the Company to generate cash with higher profit margins, and position
the Company as a semiconductor and software provider, offering customized
semiconductor solution ported on FPGA/eASIC based devices or a complete system
for the telecom access market that will utilize the Company's intellectual
property and software framework, to secure the future growth of the Company
focusing on its strengths.

 

Half Year Review

 

Operational highlights

 

During the first six months of 2023, development was completed on several
critical products and solutions including the XGS-PON, GPON and UEP2025 with
wireless link bonding. These products and solutions are currently in
discussion, testing and evaluation with customers and are targeted to generate
licensing revenues and NRE for customised product developments.

 

The completion of the first release of the UEP-2025 product, the XGS-PON OLT,
and fiber-to-the-room ("FTTR") OLT development has enabled the Company to
maintain reduced R&D staff while still pursuing future revenue
opportunities with these products and technologies.

 

During H1 2023, the Company's activities have progressed in multiple domains:

 

·    First release of the UEP bonding product delivered to our existing
bonding OEM customer who intends to complete its product for integration
during Q4/23.

·    We completed development of the XGS-PON OLT firmware ported onto our
Asian vendor's XGS-PON OLT platform, which embeds Ethernity's XGSPON MAC FPGA
SoC.

·    Completion of the FTTR gateway - we expect delays in deployment by
the customer due to the customer's own constraints, and therefore FTTR
revenues for the current year from the customer are uncertain.

·    Received a purchase order for $1.5 million from our existing fixed
wireless customer to supply the Company's data processing system-on-chip (SoC)
in staged deliveries during Q2 and Q3 2023.

 

Outlook

 

With the modified business model, the Company anticipates it will be able to
accelerate growth from its software operation stack, FPGAs, and future eASIC
based engagements. This, together with and reduction in costs already
implemented, will contribute towards the Company's ability to generate cash
for future expansion.

 

In parallel to the Company's existing FPGA business and the progress with
existing customers, the Company is in discussions to expand its UEP-2025 link
bonding offering with potential new OEM customers.

 

David Levi, Chief Executive Officer of Ethernity Networks Limited, commented:

"While it is a challenging period due to the global financial situation, I am
encouraged by the fact that there is demand for our PON offerings that have
captured interest from larger corporations, and I am hopeful that, with the
cost reductions implemented and the modified business plan, engagement in
multiple design wins for our PON technology will fulfil our further
anticipated growth."

 

For further information, please contact:

 

 Ethernity Networks Ltd                                             Tel: +972 3 748 9846
 David Levi, Chief Executive Officer

 Allenby Capital Limited (Nominated Adviser and Joint Broker)       Tel: +44 (0)20 3328 5656
 James Reeve / Piers Shimwell (Corporate Finance)

 Amrit Nahal/ Stefano Aquilino (Sales and Corporate Broking)

 Peterhouse Capital Limited (Joint Broker)                          Tel: +44 (0)20 7562 0930
 Lucy Williams/ Duncan Vasey/ Eran Zucker

 

MARKET ABUSE REGULATION

The information contained within this announcement is deemed by the Company to
constitute inside information as stipulated under the Market Abuse (amendment)
(EU Exit) Regulations 2019/310 ("MAR"). With the publication of this
announcement via a Regulatory Information Service, this inside information is
now considered to be in the public domain.

OPERATIONAL and financial REVIEW

 

During the period under review, the Company delivered revenues of $1,398,871
(H1 2022: $704,853), an increase of 98% over H1 2022.

 

The underlying gross profit increased to $996,031 (H1 2022: $428,761), and the
underlying gross margin increased to 71.2% (H1 2022: 60.83%). However, due to
a non-recurring IFRS raw material inventory impairment charge of $194K, which
the Company recorded in H1 2023, the gross profit and gross margin have been
reduced to $802,494 and 57.37% respectively.

 

EBITDA

 

The EBITDA for the six months ended 30 June 2023 is presented as follows:

 

 EBITDA                                                               US Dollar                                                                       Increase                              %
                                                                                  For the 6 months ended                                              12 months ended 31-Dec                (Decrease)

                                                                                                                                                                                            June

                                                                                  30-Jun
                                                                      2023        2022                              2022
 Revenues                                                             1,398,871   704,853                           2,937,424                         694,018                               98%
 COGS                                                                 402,840     276,092                           1,339,096                         126,748                               46%
 Inventory impairment                                                 193,537                     -                                 -                 193,537
 Gross Profit                                                         802,494     428,761                           1,598,328                         373,733                               87%
 Gross Margin %                                                       57.37%      60.83%                            54.41%                            -3pps
 Operating Loss                                                       -3,774,255  -4,478,031                        -8,696,876                        703,776                               -16%
 Add back Amortisation of Intangible Assets                           480,690     480,690                           961,380                                           -
 Add back depreciation charges on fixed assets                        67,614      53,052                            108,673                           14,562
 Add back IFRS 16 operating leases depreciation net of rent expenses  -46,324     -501                              -38,567                           -45,823
 EBITDA                                                               -3,272,275  -3,944,790                        -7,665,390                        672,515                               -17%
 Add back Share based compensation charges                            56,025      127,444                           221,362                           -71,419
 Add back impairments                                                 193,537     20,200                            599,200                           173,337
 Add back vacation accrual charges                                    -22,324     22,782                            35,646                            -45,106
 Adjusted EBITDA                                                      -3,045,037  -3,774,364                        -6,809,182                        729,327                               -19%

 

Adjusted EBITDA loss in the first six months of the year decreased by 19% to
$3,045,037 (H1 2022: $3,774,364). This decrease in adjusted EBITDA loss is
attributed to the cost savings steps the Company took in its efforts to
control spending and to progress towards generating positive cash flow. These
steps, together with the significant increase in reported revenues of
$1,398,871 vs. H1 2022 revenues of $704,853, resulted in the above-mentioned
decrease in the EBITDA loss and adjusted EBITDA loss. The gross margin is a
direct result of the revenue mix and it is anticipated that the current margin
level will continue.

 

Operating Costs

Operating expenses (before amortisation, depreciation and IFRS adjustments)
decreased by 4% from $4,203,125 to $4,041,068 during the period against the
same period in 2022.

 

Within the R&D division, the Company has cut operating expenses with
further cost cuts coming into effect during July and August. The impact of the
cost savings attributed to the above cuts will be visible in the 2023 full
year figures.

 

General and Administration costs (before amortisation, depreciation and IFRS
adjustments) have not materially changed, however G&A cost will be reduced
during second half of 2023.

 

The decrease in Marketing expenses (before amortisation, depreciation and IFRS
adjustments) is attributed to headcount cuts in the department and further
costs reduction will be visible during H2 2023.

 

After adjusting for the amortisation costs of the Development Intangible
asset, Depreciation, Share Based Compensation adjustments, and IFRS
adjustments the resultant increases (decreases) in Operating costs, as
adjusted would have been:

 

 

                                                                                US Dollar                              Increase

                                                                                                                       (Decrease)   %

 Operating Costs                                                                                                       June

                                                                                           For the 6 months ended      31-Dec
                                                                                           30-Jun
                                                                                2023       2022          2022
 Research and Development Costs net of amortisation, Share Based Compensation,  2,727,389  2,689,191     5,475,581     38,198       1%
 IFRS adjustments and Vacation accruals
 General and Administrative expenses, net of depreciation, Share Based          895,691    901,286       1,799,794     -5,595       -1%
 Compensation, IFRS adjustments, Vacation accruals and impairments
 Marketing expenses, net of Share Based Compensation and Vacation accruals      417,988    612,648       1,147,176     -194,660     -32%
 Total                                                                          4,041,068  4,203,125     8,422,551     -162,057     -4%

 

Summarised trading results

 

 Summarised Trading Results                                               US Dollar                                Increase (Decrease)  %

                                                                                                                   June

                                                                                       For the 6 months ended      31-Dec
                                                                                       30-Jun
                                                                          2023         2022          2022
 Revenues                                                                 1,398,871    704,853       2,937,424     -694,018             98%
 Gross Profit                                                             802,494      428,761       1,598,328     -373,733             87%
 Gross Margin %                                                           57.37%       60.83%        54.41%        3%                   -6%
 Operating Loss                                                           -3,774,255   -4,478,031    -8,696,876    -703,776             -16%
 Financing costs                                                          -179,529     -274,565      -573,388      -95,036              -35%
 Financing income (expenses)                                              339,335      1,249,863     1,267,652     910,528              -73%
 Net comprehensive loss for the year                                      -3,614,449   -3,502,733    -8,002,612    111,716              3%
 Basic and Diluted earnings per ordinary share                            -0.03        -0.05         -0.11         -0.02                -33%
 Weighted average number of ordinary shares for basic earnings per share  108,252,292  75,367,394    76,013,296

 

Revenue Analysis

Revenues for the six months ended 30 June 2023 of $1,398,871 (2022: $704,853)
are influenced by the timing of deliveries which is dependent on the terms of
the various contracts and orders.

 

The revenue mix will continue to evolve as the Company progresses, however
with the new business model based on licensing of FPGA and ASICs, and projects
involved in delivering systems which are based on the Company's IP, the Board
anticipates that gross margin should improve.

 

Segment Reporting

The geographic mix is represented by the makeup of the products supplied, and
the main increase in revenues is attributed to sales to the Company's U.S.
based customers.

 

 SEGMENT REPORT geographic analysis
 Region         Six months ended 30 June 2023     Six months ended 30 June 2022     Year ended

31 December 2022
                US$              %                US$              %                US$        %
 United States  1,193,868        85.3%            512,650          72.7%            2,085,670  71.0%
 Israel         137,912          9.9%             149,403          21.2%            429,954    14.6%
 Asia           54,700           3.9%             42,800           6.1%             290,800    9.9%
 Europe         12,390           0.9%             0                0.0%             131,000    4.5%
 Total          1,398,870        100.0%           704,853          100.0%           2,937,424  100.0%

 

 

Financing Costs

As noted in the Annual Results for the year ended 31 December 2022, the
majority of the financing expenses and income relate to the various fundraise
deals the Company has executed.

 

It is to be noted that these equity events, albeit in essence based on raising
funds via equity issues, are nonstandard equity arrangements and have been
dealt with in terms of the guidance in IFRS9-Financial Instruments. This
guidance, albeit that it is not based on the actual cash cost of the financing
arrangements to the Company, is significantly complex in its application,
forces the recognition of the fair value of the equity issues, and essentially
creates a recognition in differences between the market price of the shares
issued at time of issue versus the actual price at which the equity is
allotted. It is not a reflection of the cash inflows and outflows of the
transactions. It is this differential or "derivative style instrument" that
needs to be subject to a fair value analysis, and the instruments, the values
received and outstanding values due being separated into equity, assets,
finance income and finance charges in terms of the IFRS-9 guidance.

 

Referring to the two fundraise deals the Company completed during the year of
2022 and the first half of 2023 being;

 

a.      Share Subscription Agreement (5G Innovation Leaders Fund) in
February 2022

b.                      Issuance of the Share and Warrants
bundle in January 2023 and May 2023

 

It has been determined that in terms of IFRS-9, part of these transactions is
to be recognised as equity and part as a liability of the Company and all
adjustments to the liability value are to be recognised through the Income
Statement. In both cases the equity differential based on allotment price and
fair value at time of allotment charges to the income statement.

 

The Financing Expenses and Finance Income in the Income Statement that relate
to the above-mentioned transactions are thus summarised as follows:

 

 Financing expenses for the period ended June 30 2023
 01.2023 Placing warrants  $10,096  Initial expense in respect of warrants issued to broker
 Total                     $10,096

 

 Financing income for the period ended June 30 2023
 01.2023 Placing warrants    $105,329  Finance income in respect of 6p warrants liability adjusted to fair value as
                                       of June 30 2023
 5G Innovation Leaders Fund  $80,034   Net adjustment to fair value of remaining unsettled share subscription
                                       agreement as at June 30 2023
  Total                      $185,363

 

 

Going Concern

Based on the major cut in expenses and the modified business model, licensing
discussion and negotiations with major Telecom manufacturers, and in the light
of enquiries made by the Directors as to business status  of the Company, as
well as bearing in mind the ability and success of the Company to raise funds
previously, the Directors have a reasonable expectation that the Company will
have access to adequate resources to continue in operational existence for the
foreseeable future and therefore have adopted the going concern basis of
preparation in the financial statements.

 

Other than the points outlined above, there are no items on the Balance Sheet
that warrant further discussion outside of the disclosures made in the Interim
Unaudited Financial Statements presented below.

 

FORWARD LOOKING STATEMENTS

 

This announcement includes statements that are, or may be deemed to be,
"forward-looking statements". By their nature, forward-looking statements
involve risk and uncertainty since they relate to future events and
circumstances. Actual results may, and often do, differ materially from any
forward-looking statements. Any forward-looking statements in this
announcement reflect Ethernity's view with respect to future events as at the
date of this announcement. Save as required by law or by the AIM Rules for
Companies, Ethernity undertakes no obligation to publicly revise any
forward-looking statements in this announcement, following any change in its
expectations or to reflect events or circumstances after the date of this
announcement.

 

By order of the Board

 

Ayala Deutsch

VP Finance

20 September 2023

 

Interim Unaudited Financial Statements

as at 30 June 2023

 

STATEMENTS OF FINANCIAL POSITION

                                                            US dollars
                                                            30 June                     31 December
                                                            2023          2022          2022
                                                            Unaudited                   Audited
 ASSETS
 Current
 Cash and cash equivalents                                  136,872       4,164,415     715,815
 Trade receivables                                          1,465,637     1,273,328     1,299,072
 Inventories                                        5       890,897       771,122       773,076
 Other current assets                                       577,290       234,263       343,872
 Current assets                                             3,070,696     6,443,128     3,131,835

 Non-Current
 Property and equipment                                     891,478       800,194       810,326
 Intangible asset                                           4,982,110     5,943,490     5,462,800
 Right-of-use asset                                         2,658,699     2,982,310     2,816,641
 Other long term assets                                     34,524        35,767        35,689
 Non-current assets                                         8,566,811     9,761,761     9,125,456

 Total assets                                               11,637,507    16,204,889    12,257,291

 LIABILITIES AND EQUITY
 Current
 Short Term Borrowings                                      403,492       74,286        428,935
 Trade payables                                             1,010,240     739,258       785,583
 Liability related to share subscription agreement          1,510,000     2,060,000     1,836,555
 Warrants liability                                         27,215        5,033         -
 Other current liabilities                                  1,247,660     1,100,706     1,121,909
 Current liabilities                                        4,198,607     3,979,283     4,172,982

 Non-Current
 Lease liability                                            2,278,634     2,625,598     2,505,777
 Non-current liabilities                                    2,278,634     2,625,598     2,505,777

 Total liabilities                                          6,477,241     6,604,881     6,678,759

 Equity
 Share capital                                              38,500        21,152        21,904
 Share premium                                              43,873,332    40,402,890    40,786,623
 Other components of equity                                 1,318,269     1,131,473     1,225,391
 Accumulated deficit                                        (40,069,835)  (31,955,507)  (36,455,386)
 Total equity                                               5,160,266     9,600,008     5,578,532

 Total liabilities and equity                               11,637,507    16,204,889    12,257,291

 

The accompanying notes are an integral part of the interim financial
statements.

STATEMENTS OF COMPREHENSIVE LOSS

 

 

                                                                                      US dollars
                                                                                      Six months ended          For the year ended

31 December
                                                                                      30 June
                                                                                      2023         2022         2022
                                                                            Note      Unaudited                 Audited

 Revenue                                                                    8         1,398,871    704,853      2,937,424
 Cost of sales                                                                        596,377      276,092      1,339,096
 Gross profit                                                                         802,494      428,761      1,598,328
 Research and development expenses                                                    3,241,579    3,276,067    6,618,795
 General and administrative expenses                                                  926,293      1,001,705    2,523,916
 Marketing expenses                                                                   408,877      629,020      1,167,534
 Other income                                                                         -            -            (15,041)
 Operating loss                                                                       (3,774,255)  (4,478,031)  (8,696,876)

 Financing costs                                                            6         (163,008)    (274,565)    (573,388)

 Financing income                                                           7         322,814      1,249,863    1,267,652

 Loss before tax                                                                      (3,614,449)  (3,502,733)  (8,002,612)

 Tax expense                                                                          -            -            -

 Net comprehensive loss for the period                                                (3,614,449)  (3,502,733)  (8,002,612)

 Basic and diluted loss per ordinary share                                            (0.03)       (0.05)       (0.11)

 Weighted average number of ordinary shares for basic and diluted loss per            108,252,292  75,367,394   76,013,296
 share

 

 

The accompanying notes are an integral part of the interim financial
statements.

STATEMENTS OF CHANGES IN EQUITY

 

                                                                                  US dollars
                                                            Number of shares      Share capital      Share premium      Other components of equity      Accumulated deficit      Total equity

 Balance at 1 January 2023 (Audited)                        78,084,437            21,904             40,786,623         1,225,391                       (36,455,386)             5,578,532
 Employee share-based compensation                          -                     -                  -                  56,025                          -                        56,025
 Net proceeds allocated to the issuance of ordinary shares  49,688,097            14,073             2,638,711          -                               -                        2,652,784
 Shares issued pursuant to share subscription agreement     6,629,236             1,816              244,705            -                               -                        246,521
 Expenses paid in shares and warrants                       2,388,771             707                203,293            36,853                          -                        240,853
 Net comprehensive loss for the period                      -                     -                  -                  -                               (3,614,449)              (3,614,449)
 Balance at 30 June 2023 (Unaudited)                        136,790,541           38,500             43,873,332         1,318,269                       (40,069,835)             5,160,266

 Balance at 1 January 2022 (Audited)                        75,351,738            21,140             40,382,744         1,004,029                       (28,452,774)             12,955,139
 Employee share-based compensation                          -                     -                  -                  127,444                         -                        127,444
 Expenses paid in shares                                    37,106                12                 20,146             -                               -                        20,158
 Net comprehensive loss for the period                      -                     -                  -                  -                               (3,502,733)              (3,502,733)
 Balance at 30 June 2022 (Unaudited)                        75,388,844            21,152             40,402,890         1,131,473                       (31,955,507)             9,600,008

 Balance at 1 January 2022 (Audited)                        75,351,738            21,140             40,382,744         1,004,029                       (28,452,774)             12,955,139
 Employee share-based compensation                          -                     -                  -                  221,362                         -                        221,362
 Shares issued pursuant to share subscription agreement     2,695,593             752                383,733            -                               -                        384,485
 Expenses paid in shares and warrants                       37,106                12                 20,146             -                               -                        20,158
 Net comprehensive loss for the year                        -                     -                  -                  -                               (8,002,612)              (8,002,612)
 Balance at 31 December 2022 (Audited)                      78,084,437            21,904             40,786,623         1,225,391                       (36,455,386)             5,578,532

The accompanying notes are an integral part of the interim financial
statements.

 

STATEMENTS OF CASH FLOWS

 

                                                         US dollars
                                                         Six months ended          Year ended

                                                         30 June                   31 December
                                                         2023         2022         2022
                                                         Unaudited                 Audited
 Operating activities
 Net comprehensive loss for the period                   (3,614,449)  (3,502,733)  (8,002,612)

 Non-cash adjustments
 Inventory write off                                     193,537      -             -
 Depreciation of property and equipment                  67,614       53,052       108,581
 Depreciation of right of use asset                      157,942      173,892      339,561
 Share-based compensation                                56,025       127,444      221,362
 Amortisation of intangible assets                       480,690      480,690      961,380
 Amortisation of liabilities                             (140,693)    (206,755)    (396,434)
 Foreign exchange losses on cash balances                17,328       369,053      381,480
 Revaluation of financial instruments, net               (212,120)    (1,149,960)  (984,001)
 Expenses paid in shares and options                     240,853      20,158       20,158

 Net changes in working capital
 (Increase) decrease in trade receivables                (166,565)    272,270      246,526
 (Increase) in inventories                               (311,358)    (486,312)    (488,266)
 (Increase) decrease in other current assets             (233,418)    6,701        (102,908)
 Decrease in other long-term assets                      1,165        3,189        3,267
 Increase in trade payables                              224,657      87,500       133,825
 Increase (decrease) in other liabilities                127,872      (17,733)     (12,261)
 Net cash used in operating activities                   (3,110,920)  (3,769,544)  (7,570,342)

 Investing activities
 Purchase of property and equipment                      (148,766)    (193,177)    (258,838)
 Net cash used in investing activities                   (148,766)    (193,177)    (258,838)

 Financing activities
 Proceeds from share subscription agreement              -            2,000,000    2,000,000
 Proceeds allocated to ordinary shares                   2,864,790    -            -
 Proceeds allocated to warrants                          132,544      -            -
 Issuance costs                                          (185,249)    -            (9,952)
 Proceeds from short term borrowings                     956,382      100,283      527,790
 Repayment of short-term borrowings                       (970,872)   (448,630)    (493,338)
 Repayment of lease liability                            (99,524)     (216,288)    (158,849)
 Net cash provided by financing activities               2,698,071    1,435,365    1,865,651

 Net change in cash and cash equivalents                 (561,615)    (2,527,356)  (5,963,529)
 Cash and cash equivalents, beginning of year            715,815      7,060,824    7,060,824
    Exchange differences on cash and cash equivalents    (17,328)     (369,053)    (381,480)
 Cash and cash equivalents, end of period                136,872      4,164,415    715,815

 Supplementary information:
 Interest paid during the period                         38,499       6,049        13,321
 Interest received during the period                     76           1,418        1,507

 Supplementary information on non-cash activities:
 Shares issued pursuant to share subscription agreement  246,521      -            384,485
 Expenses paid in shares and warrants                    240,853      20,158       20,158

 

The accompanying notes are an integral part of the interim financial
statements.

 

NOTES TO THE FINANCIAL STATEMENTS

 

 

NOTE 1         -     NATURE OF OPERATIONS

 

ETHERNITY NETWORKS LTD. (hereinafter: the "Company"), was incorporated in
Israel on the 15th of December 2003 as Neracore Ltd. The Company changed its
name to ETHERNITY NETWORKS LTD. on the 10th of August 2004.

 

The Company provides innovative, comprehensive networking and security
solutions on programmable hardware for accelerating telco/cloud networks
performance. Ethernity's FPGA logic offers complete Carrier Ethernet Switch
Router data plane processing firmware, PON MAC firmware and control software
with a rich set of networking features, robust security, and a wide range of
virtual function accelerations to optimise telecommunications networks.
Ethernity's complete solutions quickly adapt to customers' changing needs,
improving time-to-market and facilitating the deployment of 5G, edge
computing, and different NFV appliances including wireless backhaul with
wireless link bonding, 5G UPF, 5G CU and vRouter offload with the current
focus on 5G emerging appliances. The Company's customers are situated
worldwide.

 

 

NOTE 2         -     SUMMARY OF ACCOUNTING POLICIES

Basis of presentation of the financial statements and statement of compliance
with IFRS

 

The interim condensed financial statements for the six months ended 30 June
2023 have been prepared in accordance with IAS 34, Interim Financial
Reporting. The interim condensed financial statements do not include all the
information and disclosures required in the annual financial statements in
accordance with IFRS and should be read in conjunction with the Company's
annual financial statements as at 31 December 2022. The accounting policies
applied in the preparation of the interim condensed financial statements are
consistent with those followed in the preparation of the Company's annual
financial statements for the year ended 31 December 2022.

 

The interim condensed financial statements for the half-year ended 30 June
2023 (including comparative amounts) were approved and authorized for issue by
the board of directors on 19 September 2023.

 

NOTE 3         -      GOING CONCERN

 

The financial statements have been prepared assuming that the Company will
continue as a going concern. Under this assumption, an entity is ordinarily
viewed as continuing in business for the foreseeable future unless management
intends or has no realistic alternative other than to liquidate the entity or
to stop trading for at least, but not limited to, 12 months from the reporting
date. The assessment has been made of the Company's prospects, considering all
available information about the future, which have been included in the
financial budget, from managing working capital and among other factors such
as debt repayment schedules. Consideration has been given inter alia to the
significant values of funds raised during the year ended 31 December 2022 and
to date, the current stage of the Company's life cycle, its losses and cash
outflows, including with respect to the development of the Company's products,
the expected timing and amounts of future revenues.

 

 

As set out in the Company's annual report and the results for the year ended
31 December 2022, the Company is taking careful steps towards generating
positive cash flow from its operations during FY2023, which includes a
combination of the modified business model to focus on licensing and a
reduction in costs. The delays in existing customer contracts, combined with
the extended sales cycles being experienced by the Company place significant
uncertainty over the Company's ability to achieve the revenues previously
targeted for FY2023. Whilst revenue is therefore expected to be lower than
previously anticipated, the focus on the higher margin licensing contracts is
expected to contribute to an improved gross margin once licensing sales
commence and combined with the cost savings, an improved EBITDA.

 

Based on the above-mentioned description, and in the light of enquiries made
by the Directors as to the current liquidity position of the Company, as well
as bearing in mind the ability and success of the Company to raise funds
previously, the Directors have a reasonable expectation that the Company will
have access to adequate resources to continue in operational existence for the
foreseeable future and therefore have adopted the going concern basis of
preparation in the financial statements. The directors recognize that their
expectations are based on the success of the new business model as well as the
Company succeeding to raise funds, however should events occur that could
materially impact the forecasts and cashflows of the Company, a material
uncertainty remains that may cast a significant doubt on the Company's ability
to continue as a going concern and fulfil its obligations and liabilities in
the normal course of business in the future.

 

NOTE 4         -      SIGNIFICANT EVENTS

 

                              EQUITY RELATED
TRANSACTIONS DURING THE ACCOUNTING PERIOD

During the 6 month period ended 30 June 2023, ordinary shares of the Company
were issued, as follows:

 

                                                              Note      Number of

                                                                        ordinary shares

 Issuance of ordinary shares (issued together with warrants)   1        49,688,097
 Shares issued pursuant to share subscription agreement        2        6,629,236
 Expenses paid for in shares and warrants                               2,388,771
                                                                        58,706,104

 

 1     Details of the equity raises are as follows:

 

January 2023 equity raise

 

In January 2023 the Company issued 23,571,430 shares with 23,571,430 warrants
attached. Each share and attached warrant were issued for £0.07, realising
gross proceeds of $2.02 million (£1.65 million) and net proceeds after
issuance expenses of approximately $1.89 million (£1.54 million).

 

Each warrant was initially exercisable at £0.15 with a life term of
approximately 24 months. The warrants are not transferable, are not traded on
an exchange and have an accelerator clause, whereby these warrants may be
called by the Company if the closing mid-market share price of the Company
exceeded £0.20 over a 5-consecutive day period. If such 5-consecutive day
period condition is met, the Company may serve notice on the warrant holders
to exercise their relevant warrants within 7 calendar days, failing which,
such remaining unexercised warrants shall be cancelled.

 

As the exercise price of the warrants is denominated in GBP and not in the
Company's functional currency, it was determined that the Company's obligation
under such warrants cannot be considered as an obligation to issue a fixed
number of equity instruments in exchange for a fixed amount of cash.
Accordingly, it was determined that such warrants represent a derivative
financial liability required to be accounted for at fair value through the
profit or loss category. Upon initial recognition the Company allocated the
gross proceeds as follows: an amount of approximately $133,000 was allocated
as a derivative warrants liability with the remainder of the proceeds
amounting to $1.75 million (after deduction of the allocated issuance costs of
$0.14 million) being allocated to share capital and share premium. The
issuance expenses were allocated in a consistent manner to the above
allocation. The expenses related to the warrant component were carried to
profit or loss as an immediate expense while the expenses related to the share
capital component were netted against the amount carried to equity. In
subsequent periods the company measures the derivative financial liability at
fair value and the periodic changes in fair value are carried to profit or
loss under financing costs or financing income, as applicable. The fair value
of the derivative warrant liability is categorized as level 3 of the fair
value hierarchy.

 

The fair value valuation of the warrants was based on the Black-Scholes option
pricing model, calculated in two stages. Initially, the fair value of these
call warrants issued to investors were calculated, assuming no restrictions
applied to such call warrants. As the Company, under certain circumstances,
has a right to force the investors to either exercise their warrants or have
them cancelled, the second calculation calculates the value of the warrants as
call warrants that were issued by the investor to the company. The net fair
value results from reducing the call investor warrants fair value from the
call warrants fair value, as long as the intrinsic value of the call warrants
(share price at the period end less exercise price of the warrants) is not
greater than such value. Should the intrinsic value of the warrants be higher
than the Black-Scholes two stage method described above, then the intrinsic
value of the warrants is considered to be a more accurate measure to use in
determining the fair value. The following factors were used in calculating the
fair value of the warrants at their issuance:

 

Risk free
rate
4.2%

Volatility
82.3%

 

In May 2023, the Company changed the terms of the warrants as follows:

 Changed:                                                  From     To
 Exercise price of warrants                                £ 0.15   £ 0.060
 Share price at which accelerator clause may be activated  £ 0.20   £ 0.075

 

 

Of the 23,571,430 shares and 23,571,430 warrants subscribed for, the
director's participation in this issuance was 3,697,342 shares and 3,697,342
warrants, on the same terms that outside investors participated.

 

None of these warrants had been exercised by 30 June 2023 and their fair value
of approximately $27,000 at such date is disclosed as a warrants liability in
the statement of financial position,

 

Upon this successful equity raise being concluded, the brokers for this
transaction received 573,429 two year warrants exercisable at £0.07 per
warrant. The fair-value of these warrants at the time of issuance was
approximately $23,000. As at 30 June 2023, none of these warrants have been
exercised.

 

May 2023 equity raise

 

In May 2023 the Company issued 26,116,667 shares at £0.03 per share,
realising gross proceeds of $0.98 million (£0.78 million) and net cash
proceeds after issuance expenses paid out of $0.92 million (£0.74 million).

 

Of the 26,116,667 shares subscribed for, the director's participation in this
issuance was 916,668 shares, on the same terms that outside investors
participated.

 

The gross proceeds, after deduction of the issuance costs of $54,000, were
allocated to share capital and share premium.

 

Upon this successful equity raise being concluded, the brokers for this
transaction received 772,500 two year warrants exercisable at £0.03 per
warrant. The fair-value of these warrants at the time of issuance was
approximately $14,000. As at 30 June 2023, none of these warrants have been
exercised.

 

 

 2     Shares issued pursuant to the share subscription agreement

 

In February 2022, an institutional investor signed a follow-on share
subscription agreement with the Company, subscribing for a further $2.0
million, with a total face value of $2,060,000. In March 2022 the full $2.0
million was funded as a prepayment for the subscription shares.

 

The number of subscription shares to be issued is determined by dividing the
face value of the subscription amount by the Settlement Price.

 

The Settlement Price is equal to the sum of (i) the Reference Price and (ii)
the Additional Price.

 

The Reference Price is the average of the 3 daily volume-weighted average
prices ("VWAPs") of Shares selected by the Investor during a 15 trading day
period immediately prior to the date of notice of their issue, rounded down to
the next one tenth of a penny. The Additional Price is equal to half of the
excess of 85% of the average of the daily VWAPs of the Shares during the 3
consecutive trading days immediately prior to the date of notice of their
issue over the Reference Price.

 

The investor converted the following subscription amount during the 6 month
period ended 30 June 2023 as follows:

 

 Notice date of conversion  Amount converted - USD  Shares Issued

 21 May 2023                230,000                 6,629,236

 

As described above, the investor converts subscription amounts into shares of
the Company at a discounted price. Upon each conversion, the difference
between the actual market value of shares issued to the investor and the
amount converted, is recorded in finance costs, which in the 6 month period
ended 30 June 2023 amounted to approximately $16,000.

 

 

NOTE 5         -      INVENTORIES

 

                               US dollars
                               30 June           31 December
                               2023     2022     2022
                               Unaudited         Audited

 Components and raw materials  731,039  645,852  613,218
 Finished cards                159,858  125,270  159,858
 Total inventories             890,897  771,122  773,076

 

NOTE 6         -      FINANCING COSTS

                                                                               US dollars
                                                                               Six months ended      Year ended

                                                                               30 June               31 December
                                                                               2023       2022       2022
                                                                               Unaudited             Audited

 Bank fees and interest                                                        48,170     20,321     35,150
 Lease liability financial expenses                                            104,742    114,244    227,246
 Revaluation of liability related to share subscription agreement measured at  -          60,000
 FVTPL

                                                                                                     230,992
 Expenses allocated to issuing warrants                                        10,096     -          -
 Expenses allocated to share subscription agreement                            -          80,000     80,000
 Total financing costs                                                         163,008    274,565    573,388

 

 

NOTE 7         -     FINANCING INCOME

                                                                                US dollars
                                                                                Six months ended      Year ended

                                                                                30 June               31 December
                                                                                2023       2022       2022
                                                                                Unaudited             Audited

 Revaluation of proceeds due on account of shares (financial asset measured at  80,034     -          -
 FVTPL)
 Revaluation of warrant derivative liability                                    105,329    1,209,960  1,214,993
 Interest received                                                              76         1,418      1,507
 Exchange rate differences, net                                                 137,375    38,485     51,152
 Total financing income                                                         322,814    1,249,863  1,267,652

 

 

NOTE 8 -              SEGMENT REPORTING

The Company has implemented the principles of IFRS 8, in respect of reporting
segmented activities. In terms of IFRS 8, the management has determined that
the Company has a single area of business, being the development and delivery
of high-end network processing technology.

 

The Company's revenues are divided into the following geographical areas:

                US dollars
                Six months ended      Year ended

                30 June               31 December
                2023       2022       2022
                Unaudited             Audited

 Asia           54,700     42,800     290,800
 Europe         12,390     -          131,000
 Israel         137,912    149,403    429,954
 United States  1,193,869  512,650    2,085,670
                1,398,871  704,853    2,937,424

 

 

 

The Company's revenues are divided into the following geographical areas:

                %
                Six months ended      Year ended

                30 June               31 December
                2023       2022       2022
                Unaudited             Audited

 Asia           3.9%       6.1%       9.9%
 Europe         0.9%       -          4.5%
 Israel         9.9%       21.2%      14.6%
 United States  85.3%      72.7%      71.0%
                100.0%     100.0%     100.0%

 

Revenue from customers in the company's domicile, Israel, as well as its major
market, the United States and Asia, have been identified on the basis of the
customer's geographical locations.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IR SFMFWUEDSEFU

Recent news on Ethernity Networks

See all news